These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28991071)

  • 1. New Drugs 2017, part 3.
    Hussar DA
    Nursing; 2017 Nov; 47(11):26-32. PubMed ID: 28991071
    [No Abstract]   [Full Text] [Related]  

  • 2. New Drugs 2019, part 1.
    Hussar DA
    Nursing; 2019 Feb; 49(2):28-36. PubMed ID: 30676555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approvals in 2016: cost-benefit challenges of new anticancer agents.
    Savage P
    Nat Rev Clin Oncol; 2017 Feb; 14(3):133-134. PubMed ID: 28218257
    [No Abstract]   [Full Text] [Related]  

  • 4. New Drugs 2019, part 2.
    Hussar DA
    Nursing; 2019 May; 49(5):32-41. PubMed ID: 31022027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves new melanoma treatments.
    Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):3. PubMed ID: 22396993
    [No Abstract]   [Full Text] [Related]  

  • 6. Pioneering apoptosis-targeted cancer drug poised for FDA approval.
    Mullard A
    Nat Rev Drug Discov; 2016 Mar; 15(3):147-9. PubMed ID: 26931080
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug updates and approvals: 2018 in review.
    Mospan C; Mospan G; Byland E; Whitaker WB; Xiong L; Dunlap J; Canupp K
    Nurse Pract; 2018 Dec; 43(12):23-32. PubMed ID: 30379711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Drugs 2021, Part 1.
    Hussar DA
    Nursing; 2021 Feb; 51(2):36-44. PubMed ID: 33953097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated drug approval: FDA may get tougher; companies cite hurdles.
    Goozner M
    J Natl Cancer Inst; 2011 Mar; 103(6):455-7. PubMed ID: 21393609
    [No Abstract]   [Full Text] [Related]  

  • 10. New Drugs 2017, part 1.
    Hussar DA
    Nursing; 2017 Feb; 47(2):32-39. PubMed ID: 28060244
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA-Approved Oligonucleotide Therapies in 2017.
    Stein CA; Castanotto D
    Mol Ther; 2017 May; 25(5):1069-1075. PubMed ID: 28366767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altabax approved to treat impetigo.
    Laustsen G
    Nurse Pract; 2007 Oct; 32(10):13. PubMed ID: 17901782
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA Dysregulation to Identify Novel Therapeutic Targets.
    Croce CM
    Curr Top Microbiol Immunol; 2017; 407():191-203. PubMed ID: 28653191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs 2015, part 3.
    Hussar DA
    Nursing; 2015 Oct; 45(10):30-7; quiz 37-8. PubMed ID: 26352370
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga.
    Aartsma-Rus A; Krieg AM
    Nucleic Acid Ther; 2017 Feb; 27(1):1-3. PubMed ID: 27929755
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides.
    Aartsma-Rus A
    Nucleic Acid Ther; 2017 Apr; 27(2):67-69. PubMed ID: 28346110
    [No Abstract]   [Full Text] [Related]  

  • 17. New Drugs 2020, part 1.
    Hussar DA
    Nursing; 2020 Feb; 50(2):31-38. PubMed ID: 31895198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New therapeutic agents for acute myeloid leukemia].
    Hosono N
    Rinsho Ketsueki; 2019; 60(9):1108-1119. PubMed ID: 31597834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venetoclax plus daratumumab induce hematological CR and organ response in an AL amyloidosis patient with t(11;14).
    Ghilardi G; Stussi G; Mazzucchelli L; Röcken C; Rossi D; Gerber B
    Amyloid; 2019 Sep; 26(3):173-174. PubMed ID: 31232114
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient need, drug development, and risk.
    The Lancet Oncology
    Lancet Oncol; 2019 May; 20(5):601. PubMed ID: 31044699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.